December 2023 in “Medical Times” The MEST method increases cell yield and volume for regenerative medicine but needs more testing.
9 citations
,
July 2020 in “Cell Proliferation” Epiregulin can help hair grow and may be useful for treating hair loss.
5 citations
,
April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” The gene therapy showed significant wound healing and was safe for treating severe RDEB.
14 citations
,
January 2001 in “Current Treatment Options in Oncology” Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.
3 citations
,
August 2024 in “Journal of Cosmetic Dermatology” Combining laser therapy with hair extraction improves eyebrow scar treatment.
1 citations
,
July 2021 in “Frontiers in Oncology” Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.
9 citations
,
September 2024 in “Frontiers in Endocrinology” Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.
9 citations
,
August 2023 in “Sexual Medicine Reviews” The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology”
2 citations
,
September 2020 in “International journal of radiology & radiation therapy” Radiotherapy can cause rare changes in hair color, which should be discussed with patients.
April 2026 in “Preprints.org” Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.
Low-level laser therapy is a safe, painless method that effectively treats acne and improves skin without post-treatment care.
20 citations
,
December 2019 in “International Journal of Molecular Sciences” HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.
January 2021 in “Journal of Allergy and Therapy” Electric Follicle Stimulation may promote hair growth and density with no known side effects.
October 2024 in “Journal of the Endocrine Society” Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.
October 2025 in “Actas Dermo-Sifiliográficas” RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.
9 citations
,
February 2022 in “Biomedicines” Testosterone treatment may change estrogen receptor methylation in AFAB individuals.
March 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” L-PRF effectively improved healing and bone integration in dental implant surgery.
January 2024 in “Wiadomości Lekarskie” Glioma treatment may improve with new therapies and technologies.
Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.
June 2023 in “International Journal of Dermatology” 32 citations
,
April 2011 in “Journal of the American Academy of Dermatology” Erlotinib may cause scarring hair loss.
July 2022 in “Journal of Investigative Dermatology”
September 2021 in “Meditsinskiy sovet = Medical Council” Enriched blood plasma speeds up eardrum healing and improves hearing.
October 2022 in “Journal of the ASEAN Federation of Endocrine Societies” GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.
December 2025 in “Cureus” Hyperbaric oxygen therapy speeds up recovery and improves outcomes in hair transplants.
12 citations
,
March 2016 in “Life Sciences” The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.
1 citations
,
April 2008 in “Progrès en Urologie” Systematic end-of-trial biopsies are the most reliable way to assess outcomes.
7 citations
,
August 2015 in “Dermatologic Surgery” The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.
12 citations
,
November 2006 in “Journal of thoracic oncology” A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.